Aug. 8, 2002 Regular aspirin use among postmenopausal women may reduce their risk of developing pancreatic cancer, according to findings published in the Aug. 7 issue of the Journal of the National Cancer Institute.
Laboratory tests have suggested that nonsteroidal anti-inflammatory drugs (NSAIDs) may fight pancreatic cancer, but until now there has been only limited evidence in humans to back up this theory. In this study, researchers looked at NSAID use among more than 28,000 postmenopausal women, from 1992 through 1999.
They found that women who reported any use of aspirin had a 43% lower risk of pancreatic cancer compared with women who never took aspirin. In addition, the more aspirin use a woman reported, the less likely she was to develop pancreatic cancer. Other NSAIDs did not have the same effect. Use of NSAIDs other than aspirin did not decrease the risk of pancreatic cancer.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!